From concept to early clinical trials: 30 years of microbubble-based ultrasound-mediated drug delivery research - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Advanced Drug Delivery Reviews Année : 2024

From concept to early clinical trials: 30 years of microbubble-based ultrasound-mediated drug delivery research

Résumé

Ultrasound mediated drug delivery, a promising therapeutic modality, has evolved remarkably over the past three decades. Initially designed to enhance contrast in ultrasound imaging, microbubbles have emerged as a main vector for drug delivery, offering targeted therapy with minimized side effects. This review addresses the historical progression of this technology, emphasizing the pivotal role microbubbles play in augmenting drug extravasation and targeted delivery. We explore the complex mechanisms behind this technology, from stable and inertial cavitation to diverse acoustic phenomena, and their applications in medical fields. While the potential of ultrasound mediated drug delivery is undeniable, there are still challenges to overcome. Balancing therapeutic efficacy and safety and establishing standardized procedures are essential areas requiring attention. A multidisciplinary approach, gathering collaborations between researchers, engineers, and clinicians, is important for exploiting the full potential of this technology. In summary, this review highlights the potential of using ultrasound mediated drug delivery in improving patient care across various medical conditions.

Dates et versions

inserm-04471141 , version 1 (21-02-2024)

Identifiants

Citer

Ayache Bouakaz, Jean Michel Escoffre. From concept to early clinical trials: 30 years of microbubble-based ultrasound-mediated drug delivery research. Advanced Drug Delivery Reviews, 2024, 206, pp.115199. ⟨10.1016/j.addr.2024.115199⟩. ⟨inserm-04471141⟩
4 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More